Published in Histol Histopathol on January 01, 2004
Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities. Science (2012) 2.73
Molecular biology of lung cancer: clinical implications. Clin Chest Med (2011) 1.47
Targeted therapies for lung cancer: clinical experience and novel agents. Cancer J (2011) 1.17
Antiangiogenic therapy in lung cancer: focus on vascular endothelial growth factor pathway. Exp Biol Med (Maywood) (2010) 0.84
Rigid nanoparticle-based delivery of anti-cancer siRNA: challenges and opportunities. Biotechnol Adv (2013) 0.80
Angiogenesis in NSCLC: is vessel co-option the trunk that sustains the branches? Oncotarget (2017) 0.80
Difference in intraosseous blood vessel volume and number in osteoporotic model mice induced by spinal cord injury and sciatic nerve resection. J Bone Miner Metab (2011) 0.79
Clinical application of pharmacokinetic analysis as a biomarker of solitary pulmonary nodules: dynamic contrast-enhanced MR imaging. Magn Reson Med (2012) 0.77
Correlation of genes associated with drug response to prognosis of large cell lung carcinoma. Chin J Cancer (2011) 0.77
Plasma vascular endothelial growth factor 165 in advanced non-small cell lung cancer. Oncol Lett (2014) 0.75
Blood vessel density in Basal cell carcinomas and benign trichogenic tumors as a marker for differential diagnosis in dermatopathology. J Skin Cancer (2010) 0.75
Meta-analysis of the role of bevacizumab in extensive stage small cell lung cancer. Oncol Lett (2017) 0.75
Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression. Eur J Cancer (2002) 1.68
Imaging findings in paraspinal extra osseous Ewing sarcoma. JBR-BTR (2007) 1.24
Review. Leukocyte and endothelial cell adhesion molecules in inflammation focusing on inflammatory heart disease. In Vivo (2007) 1.18
Activation of the JNK-AP-1 signal transduction pathway is associated with pathogenesis and progression of human osteosarcomas. Bone (2003) 1.14
Human malignant tumours of the breast, as compared to their respective normal tissue, have elevated expression of the Harvey ras oncogene. Anticancer Res (1984) 1.12
The presence of proprioceptive mechanoreceptors in the remnants of the ruptured ACL as a possible source of re-innervation of the ACL autograft. Knee Surg Sports Traumatol Arthrosc (2001) 1.11
Updated diagnostic criteria for partial and complete hydatidiform moles in early pregnancy. Anticancer Res (2003) 1.02
p63 expression in benign and malignant breast lesions. Histol Histopathol (2004) 1.01
Genetic models of human cancer as a multistep process. Paradigm models of colorectal cancer, breast cancer, and chronic myelogenous and acute lymphoblastic leukaemia. J Exp Clin Cancer Res (2005) 1.00
Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) Study. Ann Oncol (2011) 0.99
Immunohistochemical expression of superoxide dismutase (MnSOD) anti-oxidant enzyme in invasive breast carcinoma. Histol Histopathol (2004) 0.96
The MAPK-AP-1/-Runx2 signalling axes are implicated in chondrosarcoma pathobiology either independently or via up-regulation of VEGF. Histopathology (2005) 0.96
Increased expression of the bcl6 and CD10 proteins is associated with increased apoptosis and proliferation in diffuse large B-cell lymphomas. Mod Pathol (2003) 0.95
Immunohistochemical study of angiogenesis and proliferative activity in epiretinal membranes. Int J Clin Pract (2005) 0.95
hMSH2 is the most commonly mutated MMR gene in a cohort of Greek HNPCC patients. Br J Cancer (2005) 0.94
The role of cadherin/catenin complex in malignant melanoma. Exp Oncol (2006) 0.94
The kinin system--bradykinin: biological effects and clinical implications. Multiple role of the kinin system--bradykinin. Hippokratia (2007) 0.92
Immunohistochemical expression of glucose transporter Glut1 and cyclin D1 in breast carcinomas with negative lymph nodes. Eur J Gynaecol Oncol (2003) 0.91
Selenium in serum and neoplastic tissue in breast cancer: correlation with CEA. Br J Cancer (2006) 0.90
Borderline clear cell adenofibroma of the ovary associated with ovarian endometriosis: a case report. Eur J Gynaecol Oncol (2012) 0.90
Tumor markers in cancer patients. an update of their prognostic significance. Part II. In Vivo (2004) 0.90
Angioleiomyoma of the uterus: report of a distinctive benign leiomyoma variant. Eur J Gynaecol Oncol (2015) 0.89
Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial. Cancer Chemother Pharmacol (2012) 0.89
Clinicopathological study of the expression of syndecan-1 in invasive breast carcinomas. correlation with extracellular matrix components. J Exp Clin Cancer Res (2004) 0.88
Immunohistochemical expression of p53, p21/waf1, rb, p16, cyclin D1, p27, Ki67, cyclin A, cyclin B1, bcl2, bax and bak proteins and apoptotic index in normal thymus. Histol Histopathol (2001) 0.88
CD44 family and gynaecological cancer. In Vivo (2004) 0.87
Immunohistochemical study of extracellular matrix components in epiretinal membranes of vitreoproliferative retinopathy and proliferative diabetic retinopathy. Eur J Ophthalmol (2005) 0.86
Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial. Cancer Chemother Pharmacol (2011) 0.86
Mucoepidermoid carcinoma of the thymus: a case presentation and a literature review. Pathol Res Pract (2004) 0.86
E-cadherin adhesion molecule and syndecan-1 expression in various thyroid pathologies. Exp Oncol (2007) 0.86
Immunohistochemical expression of Bcl-2 protein in breast lesions: correlation with Bax, p53, Rb, C-erbB-2, EGFR and proliferation indices. Anticancer Res (2001) 0.86
Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional study. Breast Cancer Res Treat (2014) 0.85
Immunohistochemical localization of metallothionein in endometrial lesions. J Pathol (2000) 0.85
In vivo cell kinetics in breast carcinogenesis. Breast Cancer Res (2001) 0.85
Involvement of dysadherin and E-cadherin in the development of testicular tumours. Br J Cancer (2005) 0.85
Factors affecting outcome after incomplete excision of cervical intraepithelial neoplasia. Eur J Gynaecol Oncol (2003) 0.85
The prognostic significance of epidermal growth factor receptor (EGFR), C-erbB-2, Ki-67 and PCNA expression in breast cancer. Anticancer Res (1996) 0.85
Gangliosides rescue neuronal cells from death after trophic factor deprivation. J Neurosci (1993) 0.85
Expression of Bax protein in gastric carcinomas. A clinicopathological and immunohistochemical study. Acta Gastroenterol Belg (2007) 0.85
The introduction of medical humanities in the undergraduate curriculum of Greek medical schools: challenge and necessity. Hippokratia (2010) 0.85
FNAC: its role, limitations and perspective in the preoperative diagnosis of breast cancer. Eur J Gynaecol Oncol (2005) 0.84
Primary cutaneous apocrine carcinoma of sweat glands: a rare case report. Case Rep Oncol (2011) 0.84
CD44s expression, in benign, borderline and malignant tumors of ovarian surface epithelium. Correlation with p53, steroid receptor status, proliferative indices (PCNA, MIB1) and survival. Anticancer Res (2004) 0.84
Prognostic evaluation of metallothionein expression in human colorectal neoplasms. J Clin Pathol (1999) 0.84
Immunohistochemical evaluation of cathepsin D expression in colorectal tumours: a correlation with extracellular matrix components, p53, pRb, bcl-2, c-erbB-2, EGFR and proliferation indices. Anticancer Res (1999) 0.84
Glycoprotein CD44 expression in colorectal neoplasms. An immuno-histochemical study including correlation with cathepsin D, extracellular matrix components, p53, Rb, bcl-2, c-erbB-2, EGFR and proliferation indices. Virchows Arch (1999) 0.83
Glycoprotein CD44 expression in benign, premalignant and malignant epithelial lesions of the larynx: an immunohistochemical study including correlation with Rb, p53, Ki-67 and PCNA. Histol Histopathol (1999) 0.83
Cytogenetic and molecular genetic abnormalities in primitive neuroectodermal tumors of the central nervous system. Anticancer Res (2000) 0.83
Immunohistochemical study of the ras oncogene expression in human breast lesions. Anticancer Res (1987) 0.83
Sensory innervation of the subregions of the scapholunate interosseous ligament in relation to their structural composition. J Hand Surg Am (2009) 0.82
Influence of propofol and volatile anaesthetics on the inflammatory response in the ventilated lung. Acta Anaesthesiol Scand (2011) 0.82
In breast carcinoma dysadherin expression is correlated with invasiveness but not with E-cadherin. Br J Cancer (2007) 0.82
Analysis of chromosomal aberrations in breast cancer by comparative genomic hybridization (CGH). Correlation with histoprognostic variables and c-erbB-2 immunoexpression. J Exp Clin Cancer Res (1999) 0.82
Solitary fibrous tumor of the urinary bladder: report of a case with long-term follow-up and review of the literature. Eur Rev Med Pharmacol Sci (2007) 0.82
Novel mutations of the APC gene in familial adenomatous polyposis in Greek patients. Cancer Genet Cytogenet (2003) 0.82
Clinicopathological study of the expression of hsp27, pS2, cathepsin D and metallothionein in primary invasive breast cancer. Breast (2003) 0.82
Low expression of p27 protein combined with altered p53 and Rb/p16 expression status is associated with increased expression of cyclin A and cyclin B1 in diffuse large B-cell lymphomas. Mod Pathol (2001) 0.81
Thoracoabdominal wall tumour seeding after percutaneous radiofrequency ablation for recurrent colorectal liver metastatic lesion: a case report with a brief literature review. Acta Gastroenterol Belg (2007) 0.81
The enigmatic nature of apocrine breast lesions. Virchows Arch (2006) 0.81
Molecular profiling and genomic microarrays in prostate cancer. Exp Oncol (2007) 0.81
Analogies in medicine: the rare paradigm of the Maltese (white) cross. Intern Med J (2006) 0.81
Gastric calcifying fibrous tumor: a very rare case report. Case Rep Oncol (2012) 0.81
Lipomatosis of the parotid gland in a 9-year-old male. Int J Clin Pract (2009) 0.81
Correlation of mammographic appearance and molecular prognostic factors in high-grade breast carcinomas. Eur J Gynaecol Oncol (2006) 0.81
Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features. J Exp Clin Cancer Res (2004) 0.81
The role of fine-needle aspiration biopsy in the management of patients with thyroid nodules. In Vivo (2005) 0.81
The role of E-cadherin/catenin complex in laryngeal cancer. Exp Oncol (2005) 0.81
Transvaginal uterine ultrasonography compared with endometrial biopsy for the detection of endometrial disease in perimenopausal women with uterine bleeding. Anticancer Res (2002) 0.80
Expression of matrix metalloproteinase-9 (gelatinase B) in benign, premalignant and malignant laryngeal lesions. Histol Histopathol (2006) 0.80
Elevated expression of the myc gene in human benign and malignant breast lesions compared to normal tissue. Anticancer Res (1988) 0.80
Clinicopathological study of metallothionein immunohistochemical expression, in benign, borderline and malignant ovarian epithelial tumors. Histol Histopathol (2006) 0.80
Cytogenetic and molecular abnormalities in astrocytic gliomas (Review). Oncol Rep (2000) 0.80
p53 and c-jun expression in urinary bladder transitional cell carcinoma: correlation with proliferating cell nuclear antigen (PCNA) histological grade and clinical stage. Eur Urol (1997) 0.79
Immunohistochemical expression of cathepsin D in correlation with extracellular matrix component, steroid receptor status and proliferative indices in breast cancer. Virchows Arch (1997) 0.79
Mucinous adenocarcinoma arising in chronic perianal fistulas. J Clin Gastroenterol (2001) 0.79
Combined carcinoid-adenocarcinoma tumour of the anal canal. Scand J Gastroenterol (2004) 0.79
Bcl-2 expression in colorectal tumours. Correlation with p53, mdm-2, Rb proteins and proliferation indices. Histol Histopathol (2000) 0.79
Expression of dysadherin and E-cadherin in trophoblastic tissue in normal and abnormal pregnancies. Placenta (2006) 0.79
Histological findings in breast tissue specimens from reduction mammoplasties. Pathol Res Pract (1994) 0.79
Angiogenesis in chronic myeloproliferative diseases detected by CD34 expression. Eur J Haematol (2004) 0.79
Basement-membrane-related peri-vascular matrices not organised as a basal lamina: distribution in malignant tumours and benign lesions. J Submicrosc Cytol Pathol (2000) 0.79
Expression of cyclin-dependent kinases inhibitors p21(WAF1) and p27(KIP1) in benign, premalignant and malignant laryngeal lesions. correlation with cell cycle regulatory proteins. In Vivo (2005) 0.79
Contribution of exfoliative cytology to the diagnosis of laryngeal lesions. Acta Cytol (2000) 0.78
Immunohistochemical expression of the p53, p21/Waf-1, Rb, p16 and Ki67 proteins in multiple myeloma. Anticancer Res (2001) 0.78
Prognostic significance of p53 in the cancer of the larynx. Anticancer Res (2000) 0.78
Large loop excision of the transformation zone for treating cervical intraepithelial neoplasia: a 12-year experience. Anticancer Res (2001) 0.78
Comparative study of Harvey-ras oncogene expression with conventional clinicopathologic parameters of breast cancer. Oncology (1986) 0.78
Reinnervation after end-to-side nerve coaptation in a rat model. Am J Orthop (Belle Mead NJ) (2001) 0.78
Estrogen receptor beta (ERbeta) expression in breast carcinomas is not correlated with estrogen receptor alpha (ERalpha) and prognosis: the Greek experience. Eur J Gynaecol Oncol (2004) 0.78
Integrins in head and neck squamous cell carcinoma (HNSCC): a review of the current literature. Cell Commun Adhes (2005) 0.78
Genetic alterations of the APC gene in familial adenomatous polyposis patients of the hellenic group for the study of colorectal cancer. Anticancer Res (2003) 0.78